West Pharma (WST) Declares $0.12 Quarterly Dividend; Approves 700k Buyback

December 17, 2015 8:02 AM EST

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

West Pharma (NYSE: WST) declared a quarterly dividend of $0.12 per share, or $0.48 annualized.

The dividend will be payable on February 3, 2016, to stockholders of record on January 20, 2016, with an ex-dividend date of January 15, 2016.

The annual yield on the dividend is 0.8 percent.

The Company also announced a share repurchase program authorizing the repurchase of up to 700,000 shares of the Company's common stock from time to time on the open market or in privately negotiated transactions as permitted under Securities Exchange Act of 1934 Rule 10b-18. The number of shares to be repurchased and the timing of such transactions will depend on a variety of factors, including market conditions, but the program will commence on January 1, 2016 and is expected to be completed by December 31, 2016. The Company's previously authorized share repurchase program expires on December 31, 2015.

In addition, the Board of Directors formally appointed Chief Executive Officer Eric M. Green to the office of President of West Pharmaceutical Services, Inc. The appointment does not alter his responsibilities.

For a dividend history and other dividend-related data on West Pharma (WST) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Dividends, Management Changes, Stock Buybacks

Related Entities